Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: IL-1β-primed mesenchymal stromal cells exert enhanced therapeutic effects to alleviate Chronic Prostatitis/Chronic Pelvic Pain Syndrome through systemic immunity

Fig. 6

Expression of inflammation-related pathways decreased after treatment, and inflammation in the prostate was reduced. A Western blotting was used to detect the phosphorylation of P65, STAT3, JNK, ERK and P38 in the prostates of the saline, MSC, and IL-1β-primed MSC groups after treatment (n = 6 per group). B The inflammation score and HE-stained slices of prostate tissue indicated the inflammation level after MSC infusion (n = 6 per group). C Inflammatory factors in the prostates of the saline, MSC, and IL-1β-primed MSC groups by Biolegendplex™ bead-based immunoassays (n = 6 per group). Error bars indicate SD. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512